Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01KQW
|
|||
Former ID |
DIB009494
|
|||
Drug Name |
ID-93/GLA-SE
|
|||
Indication | Tuberculosis [ICD-11: 1B10-1B1Z; ICD-10: A15-A19, B90] | Phase 2 | [1] | |
Company |
Infectious disease research institute; aeras global tb vaccine foundation
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Mycobacterium Fusion protein Rv2608-Rv3619-Rv3620-Rv1813 (MycB antigens) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036024) | |||
REF 2 | US patent application no. US20150182612 A1. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.